The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
An osteosarcoma (OS) is a cancerous tumor in a bone. Specifically, it is an aggressive malignant neoplasm that arises from primitive transformed cells of mesenchymal origin (and thus a sarcoma) and that exhibits osteoblastic differentiation and produces malignant osteoid. Osteosarcoma is the most common histological form of primary bone cancer. It is most prevalent in teenagers and young adults.
Global Osteosarcoma market is projected to reach US$ 677.7 million in 2029, increasing from US$ 518.2 million in 2022, with the CAGR of 3.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Osteosarcoma market research.
Osteosarcoma is the eighth-most common form of childhood cancer, comprising 2.4% of all malignancies in pediatric patients, and about 20% of all primary bone cancers. Incidence rates for osteosarcoma in U.S. patients under 20 years of age are estimated at 5.0 per million per year in the general population, with a slight variation between individuals of black, Hispanic, and white ethnicities (6.8, 6.5, and 4.6 per million per year, respectively). It is slightly more common in males (5.4 per million per year) than in females (4.0 per million per year).
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Osteosarcoma market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company (Partial List)
- Pfizer
- Spectrum Pharmaceuticals
- Hikma Pharmaceuticals
- Baxter
- Isofol
- Advaxis
- Bellicum Pharmaceuticals
- Novartis
Segment by Type
- Intramedullary Osteosarcoma
- Juxtacortical Osteosarcoma
- Extraskeletal Osteosarcoma
Segment by Application
- Hospital
- Clinic
- Others
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
The Osteosarcoma report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Osteosarcoma Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Intramedullary Osteosarcoma
1.2.3 Juxtacortical Osteosarcoma
1.2.4 Extraskeletal Osteosarcoma
1.3 Market by Application
1.3.1 Global Osteosarcoma Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Osteosarcoma Market Perspective (2018-2029)
2.2 Osteosarcoma Growth Trends by Region
2.2.1 Global Osteosarcoma Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Osteosarcoma Historic Market Size by Region (2018-2023)
2.2.3 Osteosarcoma Forecasted Market Size by Region (2024-2029)
2.3 Osteosarcoma Market Dynamics
2.3.1 Osteosarcoma Industry Trends
2.3.2 Osteosarcoma Market Drivers
2.3.3 Osteosarcoma Market Challenges
2.3.4 Osteosarcoma Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Osteosarcoma Players by Revenue
3.1.1 Global Top Osteosarcoma Players by Revenue (2018-2023)
3.1.2 Global Osteosarcoma Revenue Market Share by Players (2018-2023)
3.2 Global Osteosarcoma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Osteosarcoma Revenue
3.4 Global Osteosarcoma Market Concentration Ratio
3.4.1 Global Osteosarcoma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Osteosarcoma Revenue in 2022
3.5 Osteosarcoma Key Players Head office and Area Served
3.6 Key Players Osteosarcoma Product Solution and Service
3.7 Date of Enter into Osteosarcoma Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Osteosarcoma Breakdown Data by Type
4.1 Global Osteosarcoma Historic Market Size by Type (2018-2023)
4.2 Global Osteosarcoma Forecasted Market Size by Type (2024-2029)
5 Osteosarcoma Breakdown Data by Application
5.1 Global Osteosarcoma Historic Market Size by Application (2018-2023)
5.2 Global Osteosarcoma Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Osteosarcoma Market Size (2018-2029)
6.2 North America Osteosarcoma Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Osteosarcoma Market Size by Country (2018-2023)
6.4 North America Osteosarcoma Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Osteosarcoma Market Size (2018-2029)
7.2 Europe Osteosarcoma Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Osteosarcoma Market Size by Country (2018-2023)
7.4 Europe Osteosarcoma Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Osteosarcoma Market Size (2018-2029)
8.2 Asia-Pacific Osteosarcoma Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Osteosarcoma Market Size by Region (2018-2023)
8.4 Asia-Pacific Osteosarcoma Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Osteosarcoma Market Size (2018-2029)
9.2 Latin America Osteosarcoma Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Osteosarcoma Market Size by Country (2018-2023)
9.4 Latin America Osteosarcoma Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Osteosarcoma Market Size (2018-2029)
10.2 Middle East & Africa Osteosarcoma Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Osteosarcoma Market Size by Country (2018-2023)
10.4 Middle East & Africa Osteosarcoma Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Osteosarcoma Introduction
11.1.4 Pfizer Revenue in Osteosarcoma Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 Spectrum Pharmaceuticals
11.2.1 Spectrum Pharmaceuticals Company Detail
11.2.2 Spectrum Pharmaceuticals Business Overview
11.2.3 Spectrum Pharmaceuticals Osteosarcoma Introduction
11.2.4 Spectrum Pharmaceuticals Revenue in Osteosarcoma Business (2018-2023)
11.2.5 Spectrum Pharmaceuticals Recent Development
11.3 Hikma Pharmaceuticals
11.3.1 Hikma Pharmaceuticals Company Detail
11.3.2 Hikma Pharmaceuticals Business Overview
11.3.3 Hikma Pharmaceuticals Osteosarcoma Introduction
11.3.4 Hikma Pharmaceuticals Revenue in Osteosarcoma Business (2018-2023)
11.3.5 Hikma Pharmaceuticals Recent Development
11.4 Baxter
11.4.1 Baxter Company Detail
11.4.2 Baxter Business Overview
11.4.3 Baxter Osteosarcoma Introduction
11.4.4 Baxter Revenue in Osteosarcoma Business (2018-2023)
11.4.5 Baxter Recent Development
11.5 Isofol
11.5.1 Isofol Company Detail
11.5.2 Isofol Business Overview
11.5.3 Isofol Osteosarcoma Introduction
11.5.4 Isofol Revenue in Osteosarcoma Business (2018-2023)
11.5.5 Isofol Recent Development
11.6 Advaxis
11.6.1 Advaxis Company Detail
11.6.2 Advaxis Business Overview
11.6.3 Advaxis Osteosarcoma Introduction
11.6.4 Advaxis Revenue in Osteosarcoma Business (2018-2023)
11.6.5 Advaxis Recent Development
11.7 Bellicum Pharmaceuticals
11.7.1 Bellicum Pharmaceuticals Company Detail
11.7.2 Bellicum Pharmaceuticals Business Overview
11.7.3 Bellicum Pharmaceuticals Osteosarcoma Introduction
11.7.4 Bellicum Pharmaceuticals Revenue in Osteosarcoma Business (2018-2023)
11.7.5 Bellicum Pharmaceuticals Recent Development
11.8 Novartis
11.8.1 Novartis Company Detail
11.8.2 Novartis Business Overview
11.8.3 Novartis Osteosarcoma Introduction
11.8.4 Novartis Revenue in Osteosarcoma Business (2018-2023)
11.8.5 Novartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
